Search research articles
Contact Us
Filters
Showing results (51-60 of 92) with videos related to
Page
of 10
Sort By:
Communications Biology
|
May 24, 2020
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy
Rozanne Arulanandam, Zaid Taha, Vanessa Garcia, et al.
Frontiers in Immunology
|
May 8, 2023
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus
Zaid Taha, Mathieu J F Crupi, Nouf Alluqmani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2010
Synergistic interaction between oncolytic viruses augments tumor killing
Fabrice Le Boeuf, Jean-Simon Diallo, J Andrea McCart, et al.
Nature Communications
|
June 15, 2013
Model-based rational design of an oncolytic virus with improved therapeutic potential
Fabrice Le Bœuf, Cory Batenchuk, Markus Vähä-Koskela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 28, 2023
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
Boaz Wong, Anabel Bergeron, Glib Maznyi, et al.
Scientific Reports
|
February 28, 2023
Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials
Donald J Bastin, Joshua Montroy, Michael A Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma
Tae-Ho Hwang, Anne Moon, James Burke, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity
Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Theresa Falls, et al.
Plos One
|
February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Journal of Virology
|
December 11, 2012
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma
Markus J V Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 92) with videos related to
Sort By:
Page
of 10
Communications Biology
|
May 24, 2020
The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy
Rozanne Arulanandam, Zaid Taha, Vanessa Garcia, et al.
Frontiers in Immunology
|
May 8, 2023
Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus
Zaid Taha, Mathieu J F Crupi, Nouf Alluqmani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 18, 2010
Synergistic interaction between oncolytic viruses augments tumor killing
Fabrice Le Boeuf, Jean-Simon Diallo, J Andrea McCart, et al.
Nature Communications
|
June 15, 2013
Model-based rational design of an oncolytic virus with improved therapeutic potential
Fabrice Le Bœuf, Cory Batenchuk, Markus Vähä-Koskela, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 28, 2023
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
Boaz Wong, Anabel Bergeron, Glib Maznyi, et al.
Scientific Reports
|
February 28, 2023
Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials
Donald J Bastin, Joshua Montroy, Michael A Kennedy, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 21, 2011
A mechanistic proof-of-concept clinical trial with JX-594, a targeted multi-mechanistic oncolytic poxvirus, in patients with metastatic melanoma
Tae-Ho Hwang, Anne Moon, James Burke, et al.
Molecular Therapy Oncolytics
|
April 28, 2016
Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity
Marie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Theresa Falls, et al.
Plos One
|
February 2, 2011
Enhancement of vaccinia virus based oncolysis with histone deacetylase inhibitors
Heather MacTavish, Jean-Simon Diallo, Baocheng Huang, et al.
Journal of Virology
|
December 11, 2012
Resistance to two heterologous neurotropic oncolytic viruses, Semliki Forest virus and vaccinia virus, in experimental glioma
Markus J V Vähä-Koskela, Fabrice Le Boeuf, Chantal Lemay, et al.
Page
of 10